UA56991C2 - Практично безводна косметична композиція для місцевого застосування (варіанти), спосіб її виготовлення, олівець для очей та косметична плівкоутворювальна система - Google Patents

Практично безводна косметична композиція для місцевого застосування (варіанти), спосіб її виготовлення, олівець для очей та косметична плівкоутворювальна система Download PDF

Info

Publication number: UA56991C2
Authority: UA; Ukraine
Prior art keywords: cosmetic; cosmetic composition; skin; carrier; film
Prior art date: 1995-01-11

Application number

UA97073757A

Other languages

English (en)

Russian (ru)

Ukrainian (uk)

Inventor

Йоланда Лабой

Джеймз Майкл Вілмотт

Анна Шчепановскі

Original Assignee

Мері Кей Інк.

Мери Кей Инк.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-11

Filing date

1996-11-01

Publication date

2003-06-16

1996-11-01 Application filed by Мері Кей Інк., Мери Кей Инк. filed Critical Мері Кей Інк.

2003-06-16 Publication of UA56991C2 publication Critical patent/UA56991C2/uk

Links

239000000203 mixture Substances 0.000 title claims abstract description 154
239000002537 cosmetic Substances 0.000 title claims abstract description 138
238000004519 manufacturing process Methods 0.000 title claims description 7
230000000699 topical effect Effects 0.000 title abstract description 4
238000000034 method Methods 0.000 title description 7
239000002245 particle Substances 0.000 claims abstract description 57
150000001280 alpha hydroxy acids Chemical class 0.000 claims abstract description 41
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 40
229940061720 alpha hydroxy acid Drugs 0.000 claims abstract description 38
235000011187 glycerol Nutrition 0.000 claims abstract description 17
210000003491 skin Anatomy 0.000 claims description 108
239000002904 solvent Substances 0.000 claims description 54
239000004005 microsphere Substances 0.000 claims description 47
239000003795 chemical substances by application Substances 0.000 claims description 44
239000002253 acid Substances 0.000 claims description 41
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical group CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
-1 polyethylene Polymers 0.000 claims description 29
239000001993 wax Substances 0.000 claims description 29
150000007513 acids Chemical class 0.000 claims description 28
230000002209 hydrophobic effect Effects 0.000 claims description 26
229920006395 saturated elastomer Polymers 0.000 claims description 25
239000004615 ingredient Substances 0.000 claims description 24
239000000843 powder Substances 0.000 claims description 24
235000013399 edible fruits Nutrition 0.000 claims description 22
235000014655 lactic acid Nutrition 0.000 claims description 20
239000000463 material Substances 0.000 claims description 20
239000004310 lactic acid Substances 0.000 claims description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical group O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 claims description 17
229920000299 Nylon 12 Polymers 0.000 claims description 17
239000002562 thickening agent Substances 0.000 claims description 17
239000011148 porous material Substances 0.000 claims description 16
239000000344 soap Substances 0.000 claims description 16
239000004909 Moisturizer Substances 0.000 claims description 14
230000001333 moisturizer Effects 0.000 claims description 14
125000004432 carbon atom Chemical group C* 0.000 claims description 13
229920001296 polysiloxane Polymers 0.000 claims description 13
229910052751 metal Inorganic materials 0.000 claims description 12
239000002184 metal Substances 0.000 claims description 12
XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical group C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 11
239000000126 substance Substances 0.000 claims description 11
229940086555 cyclomethicone Drugs 0.000 claims description 10
239000000440 bentonite Substances 0.000 claims description 9
229910000278 bentonite Inorganic materials 0.000 claims description 9
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical group O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 9
230000015572 biosynthetic process Effects 0.000 claims description 9
230000002745 absorbent Effects 0.000 claims description 8
239000002250 absorbent Substances 0.000 claims description 8
230000001070 adhesive effect Effects 0.000 claims description 8
239000006071 cream Substances 0.000 claims description 8
239000007788 liquid Substances 0.000 claims description 8
238000012546 transfer Methods 0.000 claims description 8
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 7
239000000969 carrier Substances 0.000 claims description 7
235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 7
229920000620 organic polymer Polymers 0.000 claims description 7
229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
229940008099 dimethicone Drugs 0.000 claims description 6
239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
150000002170 ethers Chemical class 0.000 claims description 6
210000000434 stratum corneum Anatomy 0.000 claims description 6
229920005613 synthetic organic polymer Polymers 0.000 claims description 6
150000001277 beta hydroxy acids Chemical class 0.000 claims description 5
229940085262 cetyl dimethicone Drugs 0.000 claims description 5
239000008407 cosmetic solvent Substances 0.000 claims description 5
229960005215 dichloroacetic acid Drugs 0.000 claims description 5
239000010445 mica Substances 0.000 claims description 5
229910052618 mica group Inorganic materials 0.000 claims description 5
239000004200 microcrystalline wax Substances 0.000 claims description 5
235000019808 microcrystalline wax Nutrition 0.000 claims description 5
230000000717 retained effect Effects 0.000 claims description 5
239000005995 Aluminium silicate Substances 0.000 claims description 4
239000004677 Nylon Substances 0.000 claims description 4
239000004698 Polyethylene Substances 0.000 claims description 4
239000000853 adhesive Substances 0.000 claims description 4
229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
150000001342 alkaline earth metals Chemical class 0.000 claims description 4
229910052782 aluminium Inorganic materials 0.000 claims description 4
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
235000012211 aluminium silicate Nutrition 0.000 claims description 4
239000003623 enhancer Substances 0.000 claims description 4
150000002148 esters Chemical class 0.000 claims description 4
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 4
239000006083 mineral thickener Substances 0.000 claims description 4
238000002156 mixing Methods 0.000 claims description 4
229920001778 nylon Polymers 0.000 claims description 4
239000000049 pigment Substances 0.000 claims description 4
229920000573 polyethylene Polymers 0.000 claims description 4
229940098697 zinc laurate Drugs 0.000 claims description 4
GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 claims description 4
150000001298 alcohols Chemical class 0.000 claims description 3
238000013270 controlled release Methods 0.000 claims description 3
239000006185 dispersion Substances 0.000 claims description 3
150000002314 glycerols Chemical class 0.000 claims description 3
229940088597 hormone Drugs 0.000 claims description 3
239000005556 hormone Substances 0.000 claims description 3
229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
235000011090 malic acid Nutrition 0.000 claims description 3
239000011707 mineral Substances 0.000 claims description 3
230000003020 moisturizing effect Effects 0.000 claims description 3
229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 3
239000004926 polymethyl methacrylate Substances 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 3
239000007787 solid Substances 0.000 claims description 3
DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 claims description 2
239000004743 Polypropylene Substances 0.000 claims description 2
FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 2
150000001408 amides Chemical class 0.000 claims description 2
239000007844 bleaching agent Substances 0.000 claims description 2
150000002194 fatty esters Chemical class 0.000 claims description 2
239000003193 general anesthetic agent Substances 0.000 claims description 2
229940124641 pain reliever Drugs 0.000 claims description 2
229920001155 polypropylene Polymers 0.000 claims description 2
229920002635 polyurethane Polymers 0.000 claims description 2
239000004814 polyurethane Substances 0.000 claims description 2
229920000131 polyvinylidene Polymers 0.000 claims description 2
229940057429 sorbitan isostearate Drugs 0.000 claims description 2
239000000454 talc Substances 0.000 claims description 2
229910052623 talc Inorganic materials 0.000 claims description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 2
238000007046 ethoxylation reaction Methods 0.000 claims 2
239000012051 hydrophobic carrier Substances 0.000 claims 2
229920000151 polyglycol Polymers 0.000 claims 2
239000010695 polyglycol Substances 0.000 claims 2
LUPNKHXLFSSUGS-UHFFFAOYSA-M sodium;2,2-dichloroacetate Chemical compound [Na+].[O-]C(=O)C(Cl)Cl LUPNKHXLFSSUGS-UHFFFAOYSA-M 0.000 claims 2
DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 claims 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 claims 1
KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 claims 1
AIOCLJDAYKBSTO-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 AIOCLJDAYKBSTO-UHFFFAOYSA-N 0.000 claims 1
LHWUVOILCRBENG-UHFFFAOYSA-N 7-methyloctyl 7-methyloctanoate Chemical compound CC(C)CCCCCCOC(=O)CCCCCC(C)C LHWUVOILCRBENG-UHFFFAOYSA-N 0.000 claims 1
229910052582 BN Inorganic materials 0.000 claims 1
PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims 1
208000001840 Dandruff Diseases 0.000 claims 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
229940124091 Keratolytic Drugs 0.000 claims 1
229920001213 Polysorbate 20 Polymers 0.000 claims 1
239000004793 Polystyrene Substances 0.000 claims 1
229920002472 Starch Polymers 0.000 claims 1
208000000260 Warts Diseases 0.000 claims 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
229940035674 anesthetics Drugs 0.000 claims 1
239000002260 anti-inflammatory agent Substances 0.000 claims 1
229940121363 anti-inflammatory agent Drugs 0.000 claims 1
239000003212 astringent agent Substances 0.000 claims 1
239000000378 calcium silicate Substances 0.000 claims 1
229910052918 calcium silicate Inorganic materials 0.000 claims 1
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims 1
229920002301 cellulose acetate Polymers 0.000 claims 1
239000012185 ceresin wax Substances 0.000 claims 1
239000002781 deodorant agent Substances 0.000 claims 1
XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims 1
SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 claims 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
230000001530 keratinolytic effect Effects 0.000 claims 1
239000003410 keratolytic agent Substances 0.000 claims 1
150000003893 lactate salts Chemical class 0.000 claims 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 1
239000001095 magnesium carbonate Substances 0.000 claims 1
229910000021 magnesium carbonate Inorganic materials 0.000 claims 1
239000001630 malic acid Substances 0.000 claims 1
229940073555 nonoxynol-10 Drugs 0.000 claims 1
229920004906 octoxynol-11 Polymers 0.000 claims 1
229920000058 polyacrylate Polymers 0.000 claims 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
229940068977 polysorbate 20 Drugs 0.000 claims 1
229920002223 polystyrene Polymers 0.000 claims 1
229920001343 polytetrafluoroethylene Polymers 0.000 claims 1
239000004810 polytetrafluoroethylene Substances 0.000 claims 1
239000011814 protection agent Substances 0.000 claims 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
239000000377 silicon dioxide Substances 0.000 claims 1
235000012239 silicon dioxide Nutrition 0.000 claims 1
229920002050 silicone resin Polymers 0.000 claims 1
201000010153 skin papilloma Diseases 0.000 claims 1
239000001509 sodium citrate Substances 0.000 claims 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
239000008107 starch Substances 0.000 claims 1
235000019698 starch Nutrition 0.000 claims 1
230000037072 sun protection Effects 0.000 claims 1
238000012876 topography Methods 0.000 claims 1
239000011782 vitamin Substances 0.000 claims 1
229940088594 vitamin Drugs 0.000 claims 1
229930003231 vitamin Natural products 0.000 claims 1
235000013343 vitamin Nutrition 0.000 claims 1
239000013543 active substance Substances 0.000 abstract description 53
230000000694 effects Effects 0.000 abstract description 13
230000008901 benefit Effects 0.000 abstract description 11
238000011282 treatment Methods 0.000 abstract description 8
239000002798 polar solvent Substances 0.000 abstract 1
239000000047 product Substances 0.000 description 32
239000012071 phase Substances 0.000 description 20
208000033316 Acquired hemophilia A Diseases 0.000 description 15
201000000448 autoimmune hemolytic anemia Diseases 0.000 description 15
210000000744 eyelid Anatomy 0.000 description 14
230000006872 improvement Effects 0.000 description 14
230000006870 function Effects 0.000 description 13
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
206010040954 Skin wrinkling Diseases 0.000 description 12
230000004888 barrier function Effects 0.000 description 12
238000002360 preparation method Methods 0.000 description 12
150000001875 compounds Chemical class 0.000 description 10
238000005259 measurement Methods 0.000 description 10
239000000654 additive Substances 0.000 description 9
239000003814 drug Substances 0.000 description 9
239000003974 emollient agent Substances 0.000 description 9
229920000642 polymer Polymers 0.000 description 9
229940079593 drug Drugs 0.000 description 8
238000009472 formulation Methods 0.000 description 8
230000009286 beneficial effect Effects 0.000 description 7
238000012360 testing method Methods 0.000 description 7
230000037303 wrinkles Effects 0.000 description 7
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
239000004480 active ingredient Substances 0.000 description 6
230000007547 defect Effects 0.000 description 6
235000019197 fats Nutrition 0.000 description 6
125000004122 cyclic group Chemical group 0.000 description 5
SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
239000012530 fluid Substances 0.000 description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
230000007774 longterm Effects 0.000 description 4
230000035515 penetration Effects 0.000 description 4
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
238000000149 argon plasma sintering Methods 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
230000007423 decrease Effects 0.000 description 3
210000002615 epidermis Anatomy 0.000 description 3
230000001815 facial effect Effects 0.000 description 3
210000001061 forehead Anatomy 0.000 description 3
230000005923 long-lasting effect Effects 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052749 magnesium Inorganic materials 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
230000008018 melting Effects 0.000 description 3
238000002844 melting Methods 0.000 description 3
239000000178 monomer Substances 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
150000003254 radicals Chemical class 0.000 description 3
230000009467 reduction Effects 0.000 description 3
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
125000001424 substituent group Chemical group 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
239000004408 titanium dioxide Substances 0.000 description 3
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
208000002874 Acne Vulgaris Diseases 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
239000006096 absorbing agent Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
206010000496 acne Diseases 0.000 description 2
230000002411 adverse Effects 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
230000007815 allergy Effects 0.000 description 2
HSMXEPWDIJUMSS-UHFFFAOYSA-K aluminum;tetradecanoate Chemical compound [Al+3].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O HSMXEPWDIJUMSS-UHFFFAOYSA-K 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
230000003796 beauty Effects 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
230000008859 change Effects 0.000 description 2
239000008406 cosmetic ingredient Substances 0.000 description 2
JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000000975 dye Substances 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
238000004299 exfoliation Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
210000000720 eyelash Anatomy 0.000 description 2
239000012467 final product Substances 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
239000003205 fragrance Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
239000004519 grease Substances 0.000 description 2
229940051250 hexylene glycol Drugs 0.000 description 2
230000036571 hydration Effects 0.000 description 2
238000006703 hydration reaction Methods 0.000 description 2
125000001165 hydrophobic group Chemical group 0.000 description 2
238000010191 image analysis Methods 0.000 description 2
230000003993 interaction Effects 0.000 description 2
239000002085 irritant Substances 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
230000001050 lubricating effect Effects 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
229920001451 polypropylene glycol Polymers 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
239000011669 selenium Substances 0.000 description 2
230000035807 sensation Effects 0.000 description 2
150000003408 sphingolipids Chemical class 0.000 description 2
238000003756 stirring Methods 0.000 description 2
238000005728 strengthening Methods 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
239000008158 vegetable oil Substances 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
239000011701 zinc Substances 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical class CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Chemical class 0.000 description 1
ZZPQSQFQHIGCRC-OOFFSTKBSA-N (2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-c Chemical class [Zn].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ZZPQSQFQHIGCRC-OOFFSTKBSA-N 0.000 description 1
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 description 1
VIWIWXKTPWZMEW-UHFFFAOYSA-N 2-hydroxypropanoic acid;propane-1,2,3-triol Chemical compound CC(O)C(O)=O.OCC(O)CO VIWIWXKTPWZMEW-UHFFFAOYSA-N 0.000 description 1
KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 description 1
KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 1
UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
ARKKBZAGEJJTEM-UHFFFAOYSA-N 3-(2-hydroxypropanoylamino)propyl-trimethylazanium;chloride Chemical compound [Cl-].CC(O)C(=O)NCCC[N+](C)(C)C ARKKBZAGEJJTEM-UHFFFAOYSA-N 0.000 description 1
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
244000105624 Arachis hypogaea Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
239000004342 Benzoyl peroxide Substances 0.000 description 1
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
240000002791 Brassica napus Species 0.000 description 1
235000004977 Brassica sinapistrum Nutrition 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
244000020518 Carthamus tinctorius Species 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
235000019743 Choline chloride Nutrition 0.000 description 1
241000723346 Cinnamomum camphora Species 0.000 description 1
244000060011 Cocos nucifera Species 0.000 description 1
208000032170 Congenital Abnormalities Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
206010013786 Dry skin Diseases 0.000 description 1
241001553290 Euphorbia antisyphilitica Species 0.000 description 1
229940123457 Free radical scavenger Drugs 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
241000208680 Hamamelis mollis Species 0.000 description 1
244000020551 Helianthus annuus Species 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
150000000996 L-ascorbic acids Chemical class 0.000 description 1
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
240000006240 Linum usitatissimum Species 0.000 description 1
235000004431 Linum usitatissimum Nutrition 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
240000007817 Olea europaea Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
239000002202 Polyethylene glycol Chemical class 0.000 description 1
229920001616 Polymacon Polymers 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
235000004443 Ricinus communis Nutrition 0.000 description 1
240000000111 Saccharum officinarum Species 0.000 description 1
235000007201 Saccharum officinarum Nutrition 0.000 description 1
235000019485 Safflower oil Nutrition 0.000 description 1
206010039792 Seborrhoea Diseases 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
208000006981 Skin Abnormalities Diseases 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
150000001243 acetic acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000011149 active material Substances 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical class OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
229960000458 allantoin Drugs 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
150000004716 alpha keto acids Chemical class 0.000 description 1
RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Chemical class CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
DNXNYEBMOSARMM-UHFFFAOYSA-N alumane;zirconium Chemical class [AlH3].[Zr] DNXNYEBMOSARMM-UHFFFAOYSA-N 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229940064734 aminobenzoate Drugs 0.000 description 1
PECIYKGSSMCNHN-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=NC=N[C]21.O=C1N(C)C(=O)N(C)C2=NC=N[C]21 PECIYKGSSMCNHN-UHFFFAOYSA-N 0.000 description 1
229960003556 aminophylline Drugs 0.000 description 1
239000000058 anti acne agent Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
229940124340 antiacne agent Drugs 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
235000019400 benzoyl peroxide Nutrition 0.000 description 1
229960003328 benzoyl peroxide Drugs 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000007698 birth defect Effects 0.000 description 1
WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
229960001948 caffeine Drugs 0.000 description 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical compound O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 1
HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical class [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 description 1
229960000846 camphor Drugs 0.000 description 1
229930008380 camphor Natural products 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
229940106189 ceramide Drugs 0.000 description 1
150000001783 ceramides Chemical class 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
229960003178 choline chloride Drugs 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000004927 clay Substances 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
239000003581 cosmetic carrier Substances 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
238000005336 cracking Methods 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
229940120503 dihydroxyacetone Drugs 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000037336 dry skin Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
239000003759 ester based solvent Substances 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
210000004709 eyebrow Anatomy 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
235000001785 ferulic acid Nutrition 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
235000004426 flaxseed Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
230000003325 follicular Effects 0.000 description 1
210000000245 forearm Anatomy 0.000 description 1
125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
229920000140 heteropolymer Polymers 0.000 description 1
VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
239000003906 humectant Substances 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
229960001680 ibuprofen Drugs 0.000 description 1
238000002847 impedance measurement Methods 0.000 description 1
239000010954 inorganic particle Substances 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
229940100554 isononyl isononanoate Drugs 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
229960004705 kojic acid Drugs 0.000 description 1
WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
239000010985 leather Substances 0.000 description 1
229960004194 lidocaine Drugs 0.000 description 1
239000000944 linseed oil Substances 0.000 description 1
230000002366 lipolytic effect Effects 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
239000000155 melt Substances 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
238000013508 migration Methods 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000020786 mineral supplement Nutrition 0.000 description 1
229940029985 mineral supplement Drugs 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
150000002763 monocarboxylic acids Chemical class 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
239000012454 non-polar solvent Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
239000010466 nut oil Substances 0.000 description 1
235000014571 nuts Nutrition 0.000 description 1
HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
230000037312 oily skin Effects 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000011368 organic material Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
229940101267 panthenol Drugs 0.000 description 1
235000020957 pantothenol Nutrition 0.000 description 1
239000011619 pantothenol Substances 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
150000003018 phosphorus compounds Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
230000019612 pigmentation Effects 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920000233 poly(alkylene oxides) Polymers 0.000 description 1
229920001748 polybutylene Polymers 0.000 description 1
229920001223 polyethylene glycol Chemical class 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
229960003415 propylparaben Drugs 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
239000002516 radical scavenger Substances 0.000 description 1
230000036647 reaction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
235000019172 retinyl palmitate Nutrition 0.000 description 1
239000011769 retinyl palmitate Substances 0.000 description 1
229940108325 retinyl palmitate Drugs 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
150000003870 salicylic acids Chemical class 0.000 description 1
239000004576 sand Substances 0.000 description 1
238000009738 saturating Methods 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
210000001732 sebaceous gland Anatomy 0.000 description 1
210000002374 sebum Anatomy 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
230000005808 skin problem Effects 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
239000011343 solid material Substances 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000002602 strong irritant Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
230000000475 sunscreen effect Effects 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
239000003760 tallow Substances 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000008719 thickening Effects 0.000 description 1
229940042585 tocopherol acetate Drugs 0.000 description 1
230000007704 transition Effects 0.000 description 1
HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
150000004043 trisaccharides Chemical class 0.000 description 1
239000005526 vasoconstrictor agent Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
230000001755 vocal effect Effects 0.000 description 1
238000004078 waterproofing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
229940118846 witch hazel Drugs 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1
XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0279—Porous; Hollow
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Cosmetics (AREA)

UA97073757A 1995-01-11 1996-11-01 Практично безводна косметична композиція для місцевого застосування (варіанти), спосіб її виготовлення, олівець для очей та косметична плівкоутворювальна система UA56991C2 (uk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US37122295A	1995-01-11	1995-01-11
PCT/US1996/001560 WO1996021422A1 (en)	1995-01-11	1996-01-11	Anhydrous cosmetic compositions with dermatologically active agents

Publications (1)

Publication Number	Publication Date
UA56991C2 true UA56991C2 (uk)	2003-06-16

Family

ID=23463028

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA97073757A UA56991C2 (uk)	1995-01-11	1996-11-01	Практично безводна косметична композиція для місцевого застосування (варіанти), спосіб її виготовлення, олівець для очей та косметична плівкоутворювальна система

Country Status (9)

Country	Link
EP (1)	EP0802785A1 (pt)
CN (1)	CN1172426A (pt)
AR (1)	AR003918A1 (pt)
AU (1)	AU4864396A (pt)
BR (1)	BR9607560A (pt)
CA (1)	CA2209657A1 (pt)
PL (1)	PL185239B1 (pt)
UA (1)	UA56991C2 (pt)
WO (1)	WO1996021422A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010014048A (ko) *	1997-06-20	2001-02-26	마리 케이 인코퍼레이션	미백제와 박피제를 함유한 화장품 조성물
SE9801647D0 (sv)	1998-05-12	1998-05-12	Interhealth Ab	Therapeutic composition
FR2788692B1 (fr) *	1999-01-26	2002-09-13	Oreal	Composition anhydre comprenant une phase particulaire et une phase huileuse comprenant de l'isononanoate d'isononyle, utilisation en cosmetique, pharmacie ou hygiene
US7393548B2 (en) *	1999-03-22	2008-07-01	J.P. M.E.D. Ltd.	Nano oil in glycerin emulsion
KR100348826B1 (ko) *	1999-11-12	2002-08-17	주식회사 태평양	수용성 활성성분의 피부 흡수도가 향상된 수중유형 화장료 조성물의 제조방법
US7241456B2 (en) *	2002-10-25	2007-07-10	Australian Importers Ltd.	Formulations for topical delivery of bioactive substances and methods for their use
FR2892019B1 (fr) *	2005-10-14	2007-11-30	Oreal	Procede de traitement des rides et kit de mise en oeuvre
WO2007020536A2 (en) *	2005-07-12	2007-02-22	L'oréal	Cosmetic method for the targeting of wrinkles
US8920821B2 (en)	2006-04-14	2014-12-30	Perrigo Israel Pharmaceuticals Ltd.	Pharmaceutical compositions comprising silica microspheres
US10278917B2 (en)	2006-04-14	2019-05-07	Perrigo Israel Pharmaceuticals Ltd.	Pharmaceutical compositions comprising silica microspheres
CN102014872A (zh) *	2007-12-21	2011-04-13	先灵-普劳健康护理产品公司	减少或防止皮肤失水的组合物和方法
US20110319491A1 (en) *	2008-05-30	2011-12-29	Galderma Research & Development	Anhydrous depigmenting compositions comprising, within the fatty phase thereof, a solubilized phenolic compound and a retinoid
CN102348448A (zh) *	2009-03-11	2012-02-08	Isp投资公司	增稠添加剂组合物
EP2250995B1 (en) *	2009-05-15	2020-01-15	Merck Patent GmbH	Pigment mixtures
DE102009038512A1 (de) *	2009-07-30	2011-02-10	Technische Universität Braunschweig	Arzneimittelformulierung zur Behandlung von Nagelerkrankungen
CA2920839A1 (en)	2013-08-09	2015-02-12	The Chemours Company Fc, Llc	Skin care compositions having cyclic diesters and methods thereof
WO2015095209A1 (en) *	2013-12-17	2015-06-25	Mary Kay Inc.	Delivery of active ingredients from plant materials to skin
FR3019040B1 (fr)	2014-03-31	2016-03-11	Arkema France	Composition cosmetique pour l'eclaircissement de la peau
CA2949544C (en)	2014-05-29	2023-02-28	Eveready Battery Company, Inc	Cosmetic compositions with enhanced color retention for improved skin appearance
US10744074B2 (en) *	2016-03-31	2020-08-18	L'oreal	Lip compositions
CN107582421B (zh) *	2017-10-17	2020-03-27	珀莱雅化妆品股份有限公司	一种具有抗衰老功效的化妆品用微球的制备方法
CN107982095B (zh) *	2017-10-19	2020-03-27	珀莱雅化妆品股份有限公司	一种具有抗皱功效的缓释固体微球的制备方法
CN118662367A (zh) *	2024-08-20	2024-09-20	广州芙莉莱化妆品有限公司	一种微凝珠护肤品及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5091171B2 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
LU87410A1 (fr) *	1988-12-20	1990-07-10	Cird	Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
US5053221A (en) *	1989-11-20	1991-10-01	Maybe Holding Co.	Novel mascara composition having very small particles
US5399342A (en) *	1993-02-03	1995-03-21	Dow Corning Corporation	Cosmetics with enhanced durability

1996
- 1996-01-10 AR ARP960100928A patent/AR003918A1/es not_active Application Discontinuation
- 1996-01-11 PL PL96321293A patent/PL185239B1/pl unknown
- 1996-01-11 EP EP96904572A patent/EP0802785A1/en not_active Withdrawn
- 1996-01-11 WO PCT/US1996/001560 patent/WO1996021422A1/en not_active Application Discontinuation
- 1996-01-11 CA CA002209657A patent/CA2209657A1/en not_active Abandoned
- 1996-01-11 BR BR9607560A patent/BR9607560A/pt not_active Application Discontinuation
- 1996-01-11 AU AU48643/96A patent/AU4864396A/en not_active Abandoned
- 1996-01-11 CN CN96191678A patent/CN1172426A/zh active Pending
- 1996-11-01 UA UA97073757A patent/UA56991C2/uk unknown

Also Published As

Publication number	Publication date
CN1172426A (zh)	1998-02-04
PL185239B1 (pl)	2003-04-30
CA2209657A1 (en)	1996-07-18
PL321293A1 (en)	1997-12-08
EP0802785A1 (en)	1997-10-29
AR003918A1 (es)	1998-09-30
BR9607560A (pt)	1998-12-15
AU4864396A (en)	1996-07-31
WO1996021422A1 (en)	1996-07-18
MX9705234A (es)	1998-06-28

Publication	Publication Date	Title
UA56991C2 (uk)	2003-06-16	Практично безводна косметична композиція для місцевого застосування (варіанти), спосіб її виготовлення, олівець для очей та косметична плівкоутворювальна система
US9308397B2 (en)	2016-04-12	Long-wearing cosmetic compositions
EP1740151B1 (en)	2013-10-30	Long-wearing cosmetic compositions with improved shine
KR20010014048A (ko)	2001-02-26	미백제와 박피제를 함유한 화장품 조성물
JP5357411B2 (ja)	2013-12-04	濡れ肌用ボディ化粧料
JP7079827B2 (ja)	2022-06-02	油性保湿剤を含む皮膚外用組成物
EP1018334A1 (fr)	2000-07-12	Composition cosmétique comprenant un copolymère styrène/acrylate et une phase grasse
JP2000063235A (ja)	2000-02-29	被膜形成ポリマ―を含む新規化粧品組成物
US20090285866A1 (en)	2009-11-19	Self-healing polymer compositions
JP2003535883A (ja)	2003-12-02	ポリマーで構造が与えられた液体脂肪相を含む固形エマルション
US7455850B2 (en)	2008-11-25	Two-part cosmetic product
JP2000119167A (ja)	2000-04-25	親水性の増粘化合物と多糖類アルキルエ―テルを含有するエマルション及び該エマルションを含有する組成物及びその用途
JP2008273943A (ja)	2008-11-13	水性メイクアップ化粧料
JP3634977B2 (ja)	2005-03-30	油性化粧料
JP4181976B2 (ja)	2008-11-19	油性化粧料
JP4106552B2 (ja)	2008-06-25	油性化粧料
CA2632996A1 (en)	2007-07-12	Two-coat cosmetic compositions
JP2004137225A (ja)	2004-05-13	ゲル状化粧料
JP2001206814A (ja)	2001-07-31	スチレン／アクリルコポリマーを含む化粧組成物およびその使用
JP2003113042A (ja)	2003-04-18	水中油型メ−キャップ化粧料
JP2006176453A (ja)	2006-07-06	非固形状油性化粧料
JP2001048724A (ja)	2001-02-20	欠点を目立たなくさせ皮膚をマットにするための揮発性フルオロ油の使用と該フルオロ油を使用する美容処理方法
MXPA97005234A (en)	1998-10-30	Cosmetic compositions anhydration with agents dermatologically acti
JPS6115811A (ja)	1986-01-23	化粧料
CN115887286A (zh)	2023-04-04	用于增稠的组合物、化妆品